Rob Foley

490 total citations
21 papers, 287 citations indexed

About

Rob Foley is a scholar working on Hematology, Nephrology and Surgery. According to data from OpenAlex, Rob Foley has authored 21 papers receiving a total of 287 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 8 papers in Nephrology and 3 papers in Surgery. Recurrent topics in Rob Foley's work include Erythropoietin and Anemia Treatment (10 papers), Iron Metabolism and Disorders (6 papers) and Dialysis and Renal Disease Management (6 papers). Rob Foley is often cited by papers focused on Erythropoietin and Anemia Treatment (10 papers), Iron Metabolism and Disorders (6 papers) and Dialysis and Renal Disease Management (6 papers). Rob Foley collaborates with scholars based in United States, Canada and United Kingdom. Rob Foley's co-authors include James M. Hutchinson, Dónal O’Donoghue, Colin T. White, Scott Klarenbach, Braden Manns, Marcello Tonelli, Edmond O’Riordan, François Madore, Brendan J. Barrett and Louise Moist and has published in prestigious journals such as Cancer Research, Kidney International and American Journal of Transplantation.

In The Last Decade

Rob Foley

21 papers receiving 267 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rob Foley United States 10 80 78 62 55 46 21 287
Anish Scaria Australia 9 33 0.4× 82 1.1× 56 0.9× 18 0.3× 25 0.5× 21 228
Suchai Sritippayawan Thailand 12 31 0.4× 197 2.5× 93 1.5× 42 0.8× 4 0.1× 40 456
Leslie J. Ng United States 5 72 0.9× 276 3.5× 84 1.4× 21 0.4× 34 0.7× 9 390
M. Suttorp Netherlands 9 140 1.8× 52 0.7× 36 0.6× 17 0.3× 34 0.7× 14 368
Ina Gylys-Colwell United States 8 62 0.8× 24 0.3× 77 1.2× 70 1.3× 31 0.7× 11 335
Radhika Kanthety United States 7 54 0.7× 187 2.4× 39 0.6× 19 0.3× 17 0.4× 8 358
H Abu-Aisha Saudi Arabia 11 49 0.6× 102 1.3× 31 0.5× 14 0.3× 11 0.2× 30 341
Alberto Costantini Italy 9 37 0.5× 8 0.1× 35 0.6× 13 0.2× 24 0.5× 31 263
Hafez Elzein Netherlands 9 144 1.8× 208 2.7× 19 0.3× 49 0.9× 54 1.2× 14 306
Monir Sadat Hakemi Iran 12 33 0.4× 79 1.0× 57 0.9× 9 0.2× 17 0.4× 32 348

Countries citing papers authored by Rob Foley

Since Specialization
Citations

This map shows the geographic impact of Rob Foley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob Foley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob Foley more than expected).

Fields of papers citing papers by Rob Foley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rob Foley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob Foley. The network helps show where Rob Foley may publish in the future.

Co-authorship network of co-authors of Rob Foley

This figure shows the co-authorship network connecting the top 25 collaborators of Rob Foley. A scholar is included among the top collaborators of Rob Foley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rob Foley. Rob Foley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Shieh, Perry B., James J. Dowling, Wolfgang Müller‐Felber, et al.. (2021). CLINICAL TRIAL HIGHLIGHTS. Neuromuscular Disorders. 31. S47–S47. 1 indexed citations
3.
Choi, Jonathan, Rob Foley, Jorge M. Dinis, et al.. (2018). Abstract 3648: Performance of the AVENIO ctDNA assays across multiple high-throughput next-generation sequencing platforms. Cancer Research. 78(13_Supplement). 3648–3648. 2 indexed citations
4.
Ibrahim, Hassan N., Danielle Berglund, Scott Jackson, et al.. (2017). Renal Consequences of Diabetes After Kidney Donation. American Journal of Transplantation. 17(12). 3141–3148. 17 indexed citations
5.
Hoefield, Richard, Philip A. Kalra, B. Lane, et al.. (2013). Associations of baseline characteristics with evolution of eGFR in a referred chronic kidney disease cohort. QJM. 106(10). 915–924. 13 indexed citations
6.
Indvik, Joe, et al.. (2013). Green Revolving Funds: An Introductory Guide to Implementation & Management.. 4 indexed citations
7.
Foley, Rob. (2011). Treatment of anemia in chronic kidney disease: known, unknown, and both. Journal of Blood Medicine. 2. 103–103. 3 indexed citations
8.
White, Colin T., Brendan J. Barrett, François Madore, et al.. (2008). Clinical Practice Guidelines for evaluation of anemia. Kidney International. 74(110). S4–S6. 14 indexed citations
9.
Manns, Braden, Colin T. White, François Madore, et al.. (2008). Introduction to the Canadian Society of Nephrology Clinical Practice Guidelines for the management of anemia associated with chronic kidney disease. Kidney International. 74(110). S1–S3. 9 indexed citations
10.
Moist, Louise, Rob Foley, Brendan J. Barrett, et al.. (2008). Clinical Practice Guidelines for evidence-based use of erythropoietic-stimulating agents. Kidney International. 74(110). S12–S18. 17 indexed citations
11.
Klarenbach, Scott, Louise Moist, Rob Foley, et al.. (2008). Clinical Practice Guidelines for supplemental therapies and issues. Kidney International. 74(110). S19–S24. 4 indexed citations
12.
Madore, François, Colin T. White, Rob Foley, et al.. (2008). Clinical Practice Guidelines for assessment and management of iron deficiency. Kidney International. 74(110). S7–S11. 28 indexed citations
13.
Solid, Craig A., Rob Foley, Jagbir Gill, David T. Gilbertson, & A.J. Collins. (2007). Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants. Kidney International. 71(5). 425–430. 11 indexed citations
14.
Ishani, Areef, Haifeng Guo, David T. Gilbertson, et al.. (2007). Time to target haemoglobin concentration (11 g/dl) risk of hospitalization and mortality among incident dialysis patients. Nephrology Dialysis Transplantation. 22(8). 2247–2255. 11 indexed citations
15.
Lane, B., et al.. (2003). End-stage renal disease in Indo-Asians in the North-West of England. QJM. 96(7). 499–504. 23 indexed citations
16.
Foley, Rob. (2003). Anaemia and the heart: what's new in 2003?. Nephrology Dialysis Transplantation. 18(90008). 13viii–16. 5 indexed citations
17.
O’Riordan, Edmond, Dwight W. Lambe, Dónal O’Donoghue, John P. New, & Rob Foley. (2003). Variation in dialysis patient mortality by Health Authority. QJM. 96(10). 739–745. 6 indexed citations
18.
O’Riordan, Edmond, Robert P. Willert, Roy Reeve, et al.. (2001). Isolated sarcoid granulomatous interstitial nephritis: review of five cases at one center.. PubMed. 55(4). 297–302. 45 indexed citations
19.
Hutchinson, James M. & Rob Foley. (1999). Method of physician remuneration and rates of antibiotic prescription.. PubMed. 160(7). 1013–7. 62 indexed citations
20.
Jones, Kevin, Conrad M. Harris, Stephen Bogle, Rob Foley, & Tim Usherwood. (1995). The effects on prescribing patterns and costs of having a special interest in asthma.. PubMed. 88(10). 570–5. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026